You are here

Phenotyping Steering Group

The Phenotyping Steering Group plays a role in assessing and developing phenotyping approaches within the IMPC pipeline

, including:

  • Establishing a series of technical meetings to look at how tests are working, baseline data and phenotypes detected.
  • Developing the IMPC Business Plan with respect to future phenotyping developments.
Name Institute
Karen Svenson* The Jackson Laboratory
Yann Herault* Institut Clinique de la Souris
Ann Flenniken Toronto Centre for Phenogenomics
Corey Reynolds Baylor College of Medicine
David West Children's Hospital Oakland Research Institute
Jacqui White The Wellcome Trust Sanger Institute
Je Kyung Seong  Korea Mouse Phenotyping Consortium
Mark Henkelman Toronto Centre for Phenogenomics
Mohammed Selloum Institut Clinique de la Souris
Monica Justice Baylor College of Medicine
Nick Gale Regeneron
Sara Wells Medical Research Council Harwell
Shigeharu Wakana RIKEN BioResource Centre
Tania Sorg-Guss Institut Clinique de la Souris
Valerie Gailus-Durner Helmholtz Zentrum Muenchen/Infrafrontier
*Committee co-chairs